Members |
acceptabilityId |
37 F |
Preferred (foundation metadata concept) |
37-ugers svangreundersøgelse |
Preferred (foundation metadata concept) |
3705 |
Preferred (foundation metadata concept) |
38 |
Preferred (foundation metadata concept) |
38-ugers svangreundersøgelse |
Preferred (foundation metadata concept) |
380 |
Preferred (foundation metadata concept) |
39 F |
Preferred (foundation metadata concept) |
39-måneders-børneundersøgelse med eksplicit kontekst |
Preferred (foundation metadata concept) |
39-månedersundersøgelse af barn - patient ikke fremmødt |
Preferred (foundation metadata concept) |
39-månedersundersøgelse af barn ikke tilbudt |
Preferred (foundation metadata concept) |
39-månedersundersøgelse af barn ikke ønsket |
Preferred (foundation metadata concept) |
39-ugers svangreundersøgelse |
Preferred (foundation metadata concept) |
3D-mode-ultralyd |
Preferred (foundation metadata concept) |
3a |
Preferred (foundation metadata concept) |
3alpha,7alpha,12alpha-trihydroxycholestan-26-al26-dehydrogenase |
Preferred (foundation metadata concept) |
3b |
Preferred (foundation metadata concept) |
3c |
Preferred (foundation metadata concept) |
4 |
Preferred (foundation metadata concept) |
4 F |
Preferred (foundation metadata concept) |
4 dioptrier prismetest |
Preferred (foundation metadata concept) |
4 millimol kaliumudskiftninger/dag |
Preferred (foundation metadata concept) |
4 millimol kaliumudskiftninger/kg legemsvægt |
Preferred (foundation metadata concept) |
4 millimol kaliumudskiftninger/måltid |
Preferred (foundation metadata concept) |
4 på Glasgow comaskalaen |
Preferred (foundation metadata concept) |
4 tidligere graviditeter |
Preferred (foundation metadata concept) |
4 timer |
Preferred (foundation metadata concept) |
4 timer efter dosering |
Preferred (foundation metadata concept) |
4,4'-dihydroxybiphenyl |
Preferred (foundation metadata concept) |
4,4'-dihydroxybiphenyl |
Preferred (foundation metadata concept) |
4,5-Dihydroxyphthalatdecarboxylase |
Preferred (foundation metadata concept) |
4,5-års-børneundersøgelse med eksplicit kontekst |
Preferred (foundation metadata concept) |
4,5-årsundersøgelse - patient ikke fremmødt |
Preferred (foundation metadata concept) |
4,5-årsundersøgelse ikke tilbudt |
Preferred (foundation metadata concept) |
4,5-årsundersøgelse ikke ønsket |
Preferred (foundation metadata concept) |
4-6 gange om dagen |
Preferred (foundation metadata concept) |
4-Carboxymuconolactondecarboxylase |
Preferred (foundation metadata concept) |
4-Cresoldehydrogenase (hydroxylerende) |
Preferred (foundation metadata concept) |
4-Enoyl-CoA-reductase (NADPH) |
Preferred (foundation metadata concept) |
4-Hydroxybutyrat |
Preferred (foundation metadata concept) |
4-Hydroxybutyratdehydrogenase |
Preferred (foundation metadata concept) |
4-Hydroxyglutamataminotransferase |
Preferred (foundation metadata concept) |
4-Hydroxymandelatoxidase |
Preferred (foundation metadata concept) |
4-Hydroxyphenylacetat-1-monooxygenase |
Preferred (foundation metadata concept) |
4-Methoxybenzoatmonooxygenase (O-demethylerende) |
Preferred (foundation metadata concept) |
4-Methyloxaloacetatesterase |
Preferred (foundation metadata concept) |
4-Nitrophenylphosphatase |
Preferred (foundation metadata concept) |
4-Trimethylammoniobutyraldehyddehydrogenase |
Preferred (foundation metadata concept) |
4-acetamidobutyryl-CoA-deacetylase |
Preferred (foundation metadata concept) |
4-alpha-Glucanotransferase |
Preferred (foundation metadata concept) |
4-amino-N,N-diethylanilinsulfat |
Preferred (foundation metadata concept) |
4-amino-N,N-diethylanilinsulfat |
Preferred (foundation metadata concept) |
4-aminoazobenzen |
Preferred (foundation metadata concept) |
4-aminoazobenzen |
Preferred (foundation metadata concept) |
4-aminobutansyrereceptor-antagonist |
Preferred (foundation metadata concept) |
4-aminobutyrataminotransferase |
Preferred (foundation metadata concept) |
4-aminobutyrataminotransferase-inhibitor |
Preferred (foundation metadata concept) |
4-aminobutyrataminotransferase-inhibitor |
Preferred (foundation metadata concept) |
4-aminopyridin |
Preferred (foundation metadata concept) |
4-aminoquinolin |
Preferred (foundation metadata concept) |
4-androsten-3,17-dion-monooxygenase |
Preferred (foundation metadata concept) |
4-chlor-3-cresol |
Preferred (foundation metadata concept) |
4-chlor-3-cresol |
Preferred (foundation metadata concept) |
4-coumarat-CoA-ligase |
Preferred (foundation metadata concept) |
4-delt fraktur |
Preferred (foundation metadata concept) |
4-deoxy-L-threo-5-hexosuloseuronatketolisomerase |
Preferred (foundation metadata concept) |
4-hjulet terrængående køretøj |
Preferred (foundation metadata concept) |
4-hydroxy-2-oxoglutarataldolase |
Preferred (foundation metadata concept) |
4-hydroxy-2-oxoglutarataldolasemangel |
Preferred (foundation metadata concept) |
4-hydroxy-4-methyl-2-oxoglutarataldolase |
Preferred (foundation metadata concept) |
4-hydroxyalprazolam |
Preferred (foundation metadata concept) |
4-hydroxybenzoatdekarboxylase |
Preferred (foundation metadata concept) |
4-hydroxycumarin |
Preferred (foundation metadata concept) |
4-hydroxyphenylacetat-3-monooxygenase |
Preferred (foundation metadata concept) |
4-hydroxyphenylpyruvatdioxygenase |
Preferred (foundation metadata concept) |
4-hydroxyphenylpyruvatdioxygenasemangel |
Preferred (foundation metadata concept) |
4-hydroxyprolinepimerase |
Preferred (foundation metadata concept) |
4-methoxyamphetamin |
Preferred (foundation metadata concept) |
4-methylaminophenolsulfat |
Preferred (foundation metadata concept) |
4-methylenglutamat--ammoniakligase |
Preferred (foundation metadata concept) |
4-oxoprolinreductase |
Preferred (foundation metadata concept) |
4-punktsgang |
Preferred (foundation metadata concept) |
4-pyridoxolactonase |
Preferred (foundation metadata concept) |
4-serotyper |
Preferred (foundation metadata concept) |
4-tert-butylbenzoesyre |
Preferred (foundation metadata concept) |
4-tert-butylbenzoesyre |
Preferred (foundation metadata concept) |
4-tert-butylcatechol |
Preferred (foundation metadata concept) |
4-tert-butylcatechol |
Preferred (foundation metadata concept) |
4-tert-butylphenolformaldehydresin |
Preferred (foundation metadata concept) |
4-tert-butylphenolformaldehydresin |
Preferred (foundation metadata concept) |
4-tertiary-butyl-4'-methoxy-dibenzoylmetan |
Preferred (foundation metadata concept) |
4. |
Preferred (foundation metadata concept) |
4. Di-Te-Ki-Pol- og Hib-vaccination |
Preferred (foundation metadata concept) |
4. anteriore interkostalarterie |
Preferred (foundation metadata concept) |
4. anteriore interkostalvene |
Preferred (foundation metadata concept) |
4. anthraxvaccination |
Preferred (foundation metadata concept) |
4. arcus aortae som helhed |
Preferred (foundation metadata concept) |
4. arteria metacarpalis dorsalis som helhed |
Preferred (foundation metadata concept) |
4. arteria metacarpalis palmaris som helhed |
Preferred (foundation metadata concept) |
4. articulatio capitis costae |
Preferred (foundation metadata concept) |
4. brankialfure |
Preferred (foundation metadata concept) |
4. brankiebue som helhed |
Preferred (foundation metadata concept) |